Refrigerate at 2-8 degrees Celsius (35.6-46.4 degrees Fahrenheit), protected from light, and use within 28-30 days
Initial treatment protocols typically run 8-12 weeks to establish tissue remodeling and visible improvements
A strong antioxidant, also known as the mother of all antioxidants
FOXO4-DRI distinguishes itself by offering a molecularly specific intervention: disrupting the FOXO4p53 interaction, which appears to be a survival mechanism especially enriched in senescent cells
Visual Format: Approved vs investigational status map Key Labels: Cosmetic product, compounded peptide, non-injectable route, injectable route, FDA safety concern, approved drug label, regulatory standards, product category Suggested Layout: Use a horizontal status map with four blocks: Cosmetic context, Non-injectable compounding review, Injectable safety concern, and Approved drug labeling. Add a note that product category changes evidence and safety interpretation
Ethics declarations Competing interests We disclose the following potential conflicts of interest regarding the publication of this manuscript: This research was partly funded by Cleara Biotech